Blood test aids in predicting lung cancer mortality risk
HOUSTON ― A blood-based test developed by researchers at The University of Texas MD Anderson Cancer Center can efficiently predict an individual’s risk of dying from lung cancer when combined with a personalized risk model.
According to new data published today in the Journal of Clinical Oncology, a blood-based four-protein panel (4MP), when combined with a lung cancer risk model (PLCOm2012), can better identify those at high risk of dying from lung cancer than the current U.S. Preventive Services Task Force (USPSTF) criteria.
These findings build upon previous MD Anderson research demonstrating the ...













